FDA Approves Horizant for Post-Shingles Pain

FDA Approves Horizant for Post-Shingles Pain Drug Approved for Treatment of Postherpetic Neuralgia (PHN) WebMD Health News By Jennifer Warner Reviewed by Laura J. Martin, MD More from WebMD Shingles...

Click here to read the full story.

Post a Comment
 

Enter the words shown above Enter the numbers you hear
Refresh Image Audio Help
 
Comments
No comments yet!

The Health News section does not provide medical advice, diagnosis or treatment. See additional information.

Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.